InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Hemrajani Rekha. Insider active across 3 companies, notably BioAge Labs, Inc.. In total, 5 disclosures have been logged. Split: 2 buys · 1 sell. Total volume traded: €111k. History available since 11 June 2024. The latest transaction was disclosed on 25 June 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Hemrajani Rekha is a director of Maxcyte, INC., BioAge Labs, Inc. and ALX Oncology Holdings INC. Across the 5 known filings, the recent filings observed between 2024-06-13 and 2025-08-27 show EUR 92318 of buys and EUR 19153 of sells, with the modal transaction nature listed as Attribution.